Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual Patient.
作者信息
Thomssen Christoph
机构信息
Klinik und Poliklinik für Gynäkologie, Martin-Luther-Universität Halle/Saale, Germany.
出版信息
Breast Care (Basel). 2008;3(s1):21-23. doi: 10.1159/000119749. Epub 2008 Apr 25.
Abstract
摘要
相似文献
1
Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual Patient.
Breast Care (Basel). 2008;3(s1):21-23. doi: 10.1159/000119749. Epub 2008 Apr 25.
2
How does a new patient education programme for renal recipients become situated and adapted when implemented in the daily teaching practice in a university hospital? An ethnographic observation study.
BMJ Open. 2018 Nov 25;8(11):e023005. doi: 10.1136/bmjopen-2018-023005.
3
Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment.
Eur J Surg Oncol. 2016 Jul;42(7):965-72. doi: 10.1016/j.ejso.2016.03.019. Epub 2016 Apr 20.
4
Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
Cancer Treat Rev. 2017 Apr;55:163-172. doi: 10.1016/j.ctrv.2017.03.009. Epub 2017 Mar 31.
5
[Evaluation of the immune infiltrate in breast cancer].
Bull Cancer. 2017 Jan;104(1):52-68. doi: 10.1016/j.bulcan.2016.11.010. Epub 2016 Dec 13.
6
Breast cancer treatment and work disability: patient perspectives.
Breast. 2011 Dec;20(6):534-8. doi: 10.1016/j.breast.2011.06.002. Epub 2011 Jul 1.
7
Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives.
Crit Rev Oncol Hematol. 2009 Aug;71(2):102-16. doi: 10.1016/j.critrevonc.2008.09.002. Epub 2008 Oct 14.
8
Tailoring PTV expansion to improve the dosimetry of post modified radical mastectomy intensity-modulated radiotherapy for left-sided breast cancer patients by using 4D CT combined with cone beam CT.
J Appl Clin Med Phys. 2021 May;22(5):139-146. doi: 10.1002/acm2.13244. Epub 2021 May 2.
9
Tailoring genetic/genomic services and information to the individual.
Nurs Stand. 2013;28(10):37-43. doi: 10.7748/ns2013.11.28.10.37.e7844.
10
Tailoring interventions for health behavior change in breast cancer screening.
Cancer Pract. 1997 Sep-Oct;5(5):283-8.
引用本文的文献
1
Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine.
Breast Care (Basel). 2012 Feb;7(1):7-12. doi: 10.1159/000336548. Epub 2012 Feb 21.
本文引用的文献
1
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
J Clin Oncol. 2007 Nov 20;25(33):5287-312. doi: 10.1200/JCO.2007.14.2364. Epub 2007 Oct 22.
2
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.
Ann Oncol. 2007 Jul;18(7):1133-44. doi: 10.1093/annonc/mdm271.
3
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.
J Clin Oncol. 2005 Dec 20;23(36):9312-8. doi: 10.1200/JCO.2005.03.3266.
4
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
Lancet. 2005;365(9460):671-9. doi: 10.1016/S0140-6736(05)17947-1.
5
Outcome signature genes in breast cancer: is there a unique set?
Bioinformatics. 2005 Jan 15;21(2):171-8. doi: 10.1093/bioinformatics/bth469. Epub 2004 Aug 12.
6
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
J Natl Cancer Inst. 2003 Dec 3;95(23):1758-64. doi: 10.1093/jnci/djg108.
7
A gene-expression signature as a predictor of survival in breast cancer.
N Engl J Med. 2002 Dec 19;347(25):1999-2009. doi: 10.1056/NEJMoa021967.
8
Gene expression profiling predicts clinical outcome of breast cancer.
Nature. 2002 Jan 31;415(6871):530-6. doi: 10.1038/415530a.
9
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
J Natl Cancer Inst. 2001 Jul 4;93(13):979-89. doi: 10.1093/jnci/93.13.979.
10
Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
Br J Cancer. 1999 Oct;81(4):727-32. doi: 10.1038/sj.bjc.6690755.
Zotero 插件